Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,388.50
-95.00 (-3.83%)
Jul 31, 2026, 3:30 PM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,939. The average 1-year stock price forecast is 23.05% higher than the current stock price, while the lowest is ¥2,300 (-3.71%) and the highest is ¥3,300 (+38.16%).
Price Target: ¥2,939 (+23.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ¥2,950 | Buy | Maintains | ¥2,950 | +23.51% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
366.51B
from 343.73B
Increased by 6.63%
Revenue Next Year
383.73B
from 366.51B
Increased by 4.70%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.